Trial
NCT00001962
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
—
Condition
Aplastic Anemia
Intervention
Daclizumab
Why stopped
DSMB recommended closing the study and publishing the results
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-09